DSS Inc. Leadership Bolsters Stake

Recent transactions highlight increased confidence in the company by its executive chairman and affiliates.

December 13, 2024

Strategic Investments Highlight Confidence in DSS Inc.

DSS Inc., a diversified holding company with operations across several industries, has reported significant insider stock transactions according to a recent filing. On December 10, 2024, Alset Inc. and its affiliates, under the leadership of Chan Heng Fai, acquired additional shares in DSS. These purchases reflect a notable vote of confidence in the company’s future prospects.

Alset Inc., which already holds a prominent position as DSS’s largest shareholder, purchased 820,597 newly issued shares of common stock at a price of $0.9749 per share. The deal solidifies Alset’s influence within the company and underscores its continued support of DSS’s strategic vision.

Chan Heng Fai’s Expanded Ownership

In addition to Alset’s investment, Chan Heng Fai, the executive chairman of DSS, personally acquired 205,149 shares of DSS common stock at the same per-share price. Following these transactions, Chan’s total beneficial ownership amounts to over 5.1 million shares, encompassing holdings through various entities controlled by him.

The detailed filing reveals that Chan’s ownership stake includes direct and indirect holdings through Alset Inc., Alset International Limited, Heng Fai Holdings Limited, and Global Biomedical Pte. Ltd. These entities collectively emphasize Chan’s strategic alignment with DSS’s growth trajectory.

Market analysts often interpret insider purchases as a positive signal, suggesting that key stakeholders perceive strong potential for growth or improvement within the company. While DSS has faced challenges navigating diverse industry sectors, these investments may point to renewed confidence in its operational strategy.

About DSS Inc.

DSS Inc., with its headquarters in Rochester, New York, operates as a multi-sector conglomerate. It leverages expertise in areas including real estate, biosciences, and blockchain to create shareholder value. The recent transactions by Chan and Alset Inc. may serve as a catalyst for future market interest and operational development.